
BBIO EPS Estimates
BridgeBio Pharma, Inc.
$78.67
+$0.74(+0.95%)
55
Overall
40
Value
75
Tech
52
Quality
Market Cap
$15.32B
Volume
3.28M
52W Range
$62.06 - $93.42
Target Price
$106.86
BBIO EPS estimates: the consensus estimate for BridgeBio Pharma, Inc.'s current fiscal year is -$2.55 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
BBIO EPS Estimates
- EPS estimate, current quarter
- $-0.59
- EPS estimate, next quarter
- $-0.44
- EPS estimate, current year
- $-2.55
- EPS estimate, next year
- $-0.97
- EPS growth, 3-year
- -5.06%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.78 |
| 2024 | $-2.88 |
| 2023 | $-3.95 |
| 2022 | $-3.26 |
| 2021 | $-3.90 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BBIO | $78.67 | +0.9% | 3.28M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |